Company Filing History:
Years Active: 2019-2020
Title: Innovations by Sumit Luthra in Pharmaceutical Formulations
Introduction
Sumit Luthra is an accomplished inventor based in New York, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for intravenous administration. With a total of 2 patents to his name, Luthra's work is paving the way for advancements in medical treatments.
Latest Patents
Luthra's latest patents focus on formulations of a PI3K/mTOR-inhibitor for intravenous administration. The first patent describes a pharmaceutical aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea, or a pharmaceutically acceptable salt thereof, that is a clear solution. This formulation is particularly suitable for intravenous or parenteral administration to a patient. The second patent also relates to a similar formulation, emphasizing the importance of clear solutions for effective medical delivery.
Career Highlights
Sumit Luthra is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer allows him to collaborate with some of the brightest minds in the industry, contributing to innovative solutions in healthcare.
Collaborations
Luthra has worked alongside notable colleagues such as Kevin Richard Back and Michael Cram. Their combined expertise fosters a collaborative environment that enhances the development of groundbreaking pharmaceutical formulations.
Conclusion
Sumit Luthra's contributions to pharmaceutical innovations, particularly in intravenous formulations, highlight his role as a key inventor in the industry. His patents reflect a commitment to improving patient care through advanced medical solutions.